Related Experiment Video
Updated: Apr 27, 2026
04:53
Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
Published on: May 26, 2023
1.9K
Hafnium oxide nanoparticles: toward an in vitro predictive biological effect?
Julie Marill1, Naeemunnisa Mohamed Anesary, Ping Zhang
1Nanobiotix, 60 rue de wattignies, 75012 Paris, France. julie.marill@nanobiotix.com.
Radiation Oncology (London, England)
|July 2, 2014
Summary
NBTXR3 nanoparticles enhance radiation therapy by depositing high energy doses in cancer cells. Their biological effect can be predicted in vitro based on cell uptake, radiation dose, and cancer cell radiosensitivity.
Area of Science:
- Nanomedicine
- Radiation Oncology
- Cancer Biology
Background:
- Hafnium oxide NBTXR3 nanoparticles are designed for enhanced energy deposition in cancer cells during ionizing radiation therapy.
- Understanding the in vitro biological effects of NBTXR3 nanoparticles is crucial for predicting their efficacy.
Purpose of the Study:
- To assess the predictability of the in vitro biological effect of NBTXR3 nanoparticles when combined with ionizing radiation.
- To establish a correlation between nanoparticle characteristics and radiosensitization.
Main Methods:
- Transmission electron microscopy was used to evaluate cellular uptake of NBTXR3 nanoparticles in various human cancer cell lines.
- Clonogenic survival assays were performed to measure the radioenhancement effect of NBTXR3 nanoparticles.
Main Results:
- NBTXR3 nanoparticles exhibited concentration-dependent cellular uptake, forming cytoplasmic clusters with differential uptake observed across cell line types.
- The dose enhancement factor increased with NBTXR3 concentration and radiation dose.
- Radioenhancement was predictable based on nanoparticle cluster formation, radiation dose, and cancer cell radiosensitivity.
Conclusions:
- Preliminary findings suggest that the in vitro biological effect of NBTXR3 nanoparticles with ionizing radiation is predictable.
- This predictability may aid in optimizing NBTXR3 nanoparticle-based cancer treatments.
